It is a financial services private limited company based in Shakarpur Delhi, Delhi, India, established in 2005.
2005 | Shakarpur Delhi, Delhi, India | ActiveNaman Pharma Private Limited, a active private limited company, was established on 24 November 2005 in Shakarpur Delhi, Delhi, India. Engaging in real estate financing within the real estate sector, it holds CIN: U45201DL2005PTC142940. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Anjesh Teotia (Director), Satish Kumar (Director). Past directors included Anjesh Teotia, Prashant Gupta, Preeti Jain. It holds ₹7.01 Cr open charges and ₹8.53 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 207, Aggarwal Chambers-Iv, 27, Veer Savarkar Block,, Shakarpur Delhi, Delhi, 110092.
U45201DL2005PTC142940
142940
24 November 2005
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Naman Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjesh Teotia | Director | 20 Apr 2013 | Current |
| Satish Kumar | Director | 20 Apr 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Jun 2013 | Past |
| Pramod Abcsdd | Director | 25 Apr 2013 | Past |
| Pramod Abcsdd | Director | 19 May 2011 | Past |
| Pramod Abcsdd | Director | 25 Apr 2013 | Past |
| Pramod Abcsdd | Director | 19 May 2011 | Past |
| Pramod Abcsdd | Director | 25 Apr 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Naman Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1000% increase. The company also saw a substantial improvement in profitability, with a 57.43% increase in profit. The company's net worth dipped by a decrease of 6.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Naman Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹70,123,000.00
₹85,341,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2024 | Others | ₹1.80 Cr | Open |
| 02 Feb 2023 | Others | ₹1.43 Cr | Open |
| 24 Jun 2021 | Others | ₹3.78 Cr | Open |
| 10 Oct 2020 | Others | ₹3.69 M | Satisfied |
| 06 Aug 2020 | Others | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Naman Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Naman Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naman Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 18.00 M with Charge ID 100969434 was registered on 29 Aug 2024. was documented.
Naman Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Naman Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 14.32 M with Charge ID 100670709 was registered on 02 Feb 2023. was completed.
The activity A charge with Others amounted to Rs. 37.80 M with Charge ID 100453141 was registered on 24 Jun 2021. was completed.
The activity A charge registered on 10 Oct 2020 via Charge ID 100377694 with Others was fully satisfied on 13 Jun 2021. was completed.
The CIN of Naman Pharma Private Limited is U45201DL2005PTC142940.
Naman Pharma Private Limited is headquartered at 207, Aggarwal Chambers-Iv, 27, Veer Savarkar Block,, Shakarpur Delhi, Delhi, 110092.
Naman Pharma Private Limited was incorporated on 24 November 2005.
The current directors of Naman Pharma Private Limited are
The primary industry of Naman Pharma Private Limited is Real Estate.
Naman Pharma Private Limited is unlisted.
The authorized capital of Naman Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Naman Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX